TEAMFund

TEAMFund

TEAMFund launched in 2006, founded by John W. H. Denton, a veteran of the dental and medical-device industry who previously held leadership roles at Dentsply International. The entity operates as a hybrid multi-family office and investment syndicate, aggregating capital from a concentrated network of former medical-device executives, surgeons, and healthcare entrepreneurs. Its wealth base stems principally from exits in the dental and orthopedics manufacturing sector. Strategy centers on direct equity investments in early- to late-stage medical-technology companies, with a secondary focus on healthcare-focused enterprise software. The firm has historically targeted orthopedic implants, robotic surgery platforms, dental consumables, and digital pathology tools. Confirmed portfolio exposures include companies later sold to top-10 medtech acquirers, though TEAMFund typically does not disclose its active book publicly. It sources proprietary opportunities through a clinical-advisor network, allowing it to diligence products before they reach institutional auction. TEAMFund maintains a multi-continent operational footprint, with core investment-review nodes in New York, Singapore, and Shenzhen — the latter supporting Asia-based contract-manufacturing and innovation scouting. Its Charleston office historically housed operational-diligence staff. The group operates without a disclosed aggregate AUM figure, consistent with the privacy norms of multi-family offices in the medical space. What structurally distinguishes TEAMFund from a typical healthcare venture fund is its model: it is not open to retail or institutional LPs. It only accepts capital from operators who have built and sold medical-device businesses. This creates a diligence edge — incoming deal flow is triaged by practicing surgeons and ex-CEOs who understand FDA pathway risk and hospital procurement cycles innately — and ties each member's return to their own clinical reputation.